Latest News
Dr. Michelson Advocates for Establishing a “National Institute for Cures” to Fast-Track Drug and Vaccine Development
Dr. Gary Michelson makes the case for why increased fast tracking of funding and development for innovative scientific developments is key for our future in the latest COVID-19 edition of National Academy of Inventors’ Technology & Innovation Journal.
New Cutting-Edge Cryo-Electron Microscopy Facility Exemplifies USC Michelson Center’s Vision for Convergent Bioscience
A new facility recently opened in the USC Michelson Center on Convergent Bioscience that allows scientists to view and take snapshots of biological molecules in three dimensions through a technique called cryo-electron microscopy (cryo-EM), which is a game-changer for structural biology research.
TIME’s Best Inventions of 2021 List Spotlights GIBLIB, the ‘Netflix of the Medical World’ in Michelson 20MM’s Investment Portfolio
GIBLIB is an on-demand video medical education platform featuring lectures, discussions, surgical procedures, and more from physicians and other experts.
Welcome Alternatives to Animal Testing
New legislation will allow more innovative and human-relevant testing platforms to expedite the development of promising drugs, write Dr. Gary Michelson and Dr. Aysha Akhtar.
Eliminating the Uncertainty of Cancer Care is My Life’s Mission
Cancer is not an easy target, writes Dr. Peter Kuhn, founding director of the USC Michelson Convergent Science Institute in Cancer. It consists of a disease spectrum that ranges from high lethality that is spreading rapidly to locally confined malignancies without lethality over the average lifespan.
Unique MRI Machine Installed in USC Michelson Center for Convergent Bioscience
The state-of-the-art MRI machine that was recently installed in the USC Michelson Center for Convergent Bioscience allows researchers and students to produce better, faster, and less expensive images of the human body, thus improving the capability of diagnostic imaging to detect diseases.
Nanofabrication Laboratory Opens at USC Michelson Center for Convergent Bioscience
The new, state-of-the-art John O’Brien Nanofabrication Lab is an innovation hub for research projects ranging from basic science to applied technology.
Young and Diverse Teams of Researchers Produce More Impactful Science
Diversity of thought and experience is critical to science and the scientific method, said Dr. Ansuman Satpathy of Stanford in a recent Science podcast sponsored by Michelson Philanthropies.
Climate Change is a Direct Threat to Human Health and Immunology
Climate change contributes to diseases and other health problems in vulnerable populations around the world, according to scientists and experts in a recent program sponsored by Michelson Philanthropies.
To Support Future Medical Advances, Revamp the Rules for Funding Research
Dr. Gary Michelson shares his commentary on why bold, young scientists have the potential to revolutionize scientific research and accelerate the pace of innovation.
Webinar | Healthy Planet, Healthy People: How Climate Change Impacts Human Immunology
Join researchers and policy experts at 9 a.m. PT / 12 p.m. ET on Wednesday, July 28, for a live, interactive webinar on the threats climate change poses to the human immune system and how science and innovation can mitigate some of the negative impacts, presented by Science/AAAS and Michelson Philanthropies.
A Conversation With Dr. Laura Mackay | Science Podcast
Dr. Laura Mackay, professor and laboratory head of the Peter Doherty Institute at the University of Melbourne, discusses the importance of supporting and promoting diversity in STEM with Science editor Sean Sanders, PhD.
Applications Now Open for the Michelson Philanthropies & Science Prize for Immunology
Early-career researchers can apply for the Michelson Philanthropies & Science Prize for Human Immunology from May 15 to October 1, 2021.
To Vaccinate Our Economy, Boost Support for the NIH
The National Institutes of Health (NIH) is the world’s single largest funder of medical research, the very fuel that feeds the American engine of medical discovery and the linchpin to our country’s post-COVID economic recovery.
The Best Ways to Support Early-Career Scientists
Science Editor-in-Chief Holden Thorp talks with Gary Michelson, founder of the Michelson Medical Research Foundation and co-chair of Michelson Philanthropies, about the best ways to support early-career scientists, including through prizes such as the new Michelson Philanthropies and Science Prize for Immunology.
Michelson Prizes Invites Applications for $150,000 Research Grants in Human Immunology
Michelson Medical Research Foundation and the Human Immunome Project are now welcoming applications for the 2021 Michelson Prize: Next Generation Grants. The prestigious $150,000 grants are given annually to support researchers 35 and younger who are advancing human immunology, vaccine, and immunotherapy discovery research on major global diseases.
New CSI-Cancer Lab Designed to Promote Collaboration
The USC Michelson Center for Convergent Bioscience has opened a new Convergent Science Institute in Cancer (CSI-Cancer) lab. Peter Kuhn, a founding member of the USC Michelson Center, made the announcement.
Researchers Develop New Way to Watch Pancreatic Cells Package Insulin
A team of scientists from the Bridge Institute at the USC Michelson Center for Convergent Bioscience has for the first time actually looked at a pancreatic cell as it was packaging insulin and responding to a drug treatment. Their work marks a new way to understand diabetes.
Epic Sciences and USC Michelson Center Partner to Improve Cancer Care
The USC Michelson Center for Convergent Bioscience and Epic Sciences, Inc. will work in concert to create more precise characterization of rare circulating tumor cells.
Dr. Gary Michelson Discusses Finding Cures Faster
The lives of chronic and rare disease patients depend on the positive progress of medical discoveries. In this podcast episode, Dr. Gary K. Michelson explains how investment in innovative, high-risk research can improve patient outcomes.
